Increasing numbers of peri- and post-menopausal women request “bioidentical” rather than synthetic hormones. Although there is a tendency to think of bioidentical hormones as “all-natural”, they, like synthetic hormones, are manufactured in the laboratory. In [...]
The Food and Drug Administration has approved a new progestin-only oral contraceptive called Slynd. This preparation contains the novel progestin drospirenone which is one component of the oral contraceptives (OCs) YaZ and Yasmin. (These contraceptives [...]
We commonly receive questions regarding the potential effects of oral contraceptives (birth control pills) on mood and risk for depression. Despite the prevalence of OC usage, few studies have explored the association between hormonal contraceptive [...]
According to data presented at the annual meeting of the North American Menopause Society (NAMS) in Las Vega, a growing number of perimenopausal women are asking their doctors for compounded or bioidentical hormones. Although bioidentical [...]
Women with bipolar disorder often experience fluctuating mood symptoms across the menstrual cycle, typically reporting an exacerbation of symptoms during the premenstrual phase of the cycle (Rasgon et al, 2003, 2005). Other studies have indicated [...]
Following the publication of the Women's Health Initiative report in 2002, there was a dramatic drop in the use of hormone-replacement therapy (HRT) due to concerns about increased risk of heart disease, breast cancer, and stroke. Since that time, various non-hormonal alternatives have been utilized for the treatment of menopausal symptoms, including gabapentin and various serotonin reuptake inhibitors.
